Sage Journals: Discover world-class research

Retricted access

Research article

First published 2021-10

Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer

Viktoria Florentine Koehler, Elke Berg, Pia Adam [...]

Thyroid®

Open access

Research article

First published 2019

Cabozantinib for patients with advanced hepatocellular carcinoma: a cost-effectiveness analysis

Amir Shlomai, Moshe Leshno, Daniel A. Goldstein

Therapeutic Advances in Gastroenterology

Free access

Editorial

First published 2016-12

A concise review on advances in development of small molecule anti-inflammatory therapeutics emphasising AMPK: An emerging target

Chethan Gejjalagere Honnappa, Unnikrishnan Mazhuvancherry Kesavan

International Journal of Immunopathology and Pharmacology

Open access

Research article

First published 2019

Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study

Ali Aljubran, Mahmoud A Elshenawy, Magdy Kandil [...]

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2021-7

Multi-center observational study on the adherence,quality of life,and adverse events in lung cancer patients treated with tyrosine kinase inhibitors

Jelena Rosentreter, Jürgen Alt, Marius Fried [...]

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2015-5

Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing Sarcoma

Steven Attia, Scott H. Okuno, Steven I. Robinson [...]

Rare Tumors

Open access

Review article

First published 2011

Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?

Michael R. Harrison

Clinical Medicine Insights: Oncology

Free access

Research article

First published 2016-8

Mycobacterium Cytidylate Kinase Appears to Be an Undruggable Target

Justin K. Craig, Jenni K. Risler, Kimberly A. Loesch [...]

Journal of Biomolecular Screening

Open access

Review article

First published 2020

Tyrosine Kinase Inhibitors in the Combination Therapy of HER2 Positive Breast Cancer

Xue Yang, Dapeng Wu, Shengli Yuan

Technology in Cancer Research & Treatment

Retricted access

Case report

First published 2016-4

Sorafenib-induced severe urticaria in a patient with hepatocellular cancer

Fatma Yalçın Musri, Hasan Mutlu, Derya Kıvrak Salim [...]

Journal of Oncology Pharmacy Practice

Search results